Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search



You are here Vice-Provost/CAO

Vice-Provost/Chief Academic Officer

The Vice-Provost is the Deputy President and Chief Academic Officer of the College with overall responsibility for research and education in the university and with special responsibility in relation to academic staff matters. Professor Orla Shiels was appointed 74th Vice-Provost on 3rd September 2021. The Vice-Provost/Chief Academic Officer is responsible for academic and research policy, and for strategic planning.

The Vice-Provost/Chief Academic Officer chairs the following:

 

Together with the members of these groups, he coordinates strategic planning, research, undergraduate and postgraduate education, quality and the student experience.

The Vice-Provost / Chief Academic Officer reports directly to the Provost and is an ex officio member of the Board of the College, the University Council, and Executive Officer Group.

 

Biography

Professor Orla Sheils has served as Dean of the Faculty of Health Sciences, Director of the Trinity Translational Medicine Institute (TTMI), and is currently Professor of Molecular Diagnostics and Director of Medical Ethics at the School of Medicine, Trinity College Dublin. She has a PhD in Molecular Pathology from Trinity College Dublin and a MA in Medical Law and Ethics from Kings College London.
The underlying theme of her research is to understand the causes and molecular basis of the development of disease, with particular reference to cancer, and to apply this knowledge to improving disease prevention, detection, diagnosis, and treatment. She has a particular interest in developing novel molecular diagnostics. Translational research is the common theme throughout Prof Sheils' research, linking identification of disease processes with targets for early disease detection or classification.

She has been an independent investigator since 2001 and has supervised 28 students to PhD level and 10 to MD. She works closely with industry bringing novel technologies and applications to the translational research setting.